InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Cagle Gerald D., Director. Director active across 1 company, notably Aerie Pharmaceuticals INC. Aggregated, 2 reports have been logged. Activity tracked since 17 June 2021. The latest transaction was disclosed on 17 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
1,750 shares0Common StockSEC:0001209191-21-041979
1,750 shares0Common StockSEC:0001209191-21-041979:0
2 of 2 declarations
About Cagle Gerald D.
Gerald D. Cagle serves as a Director at Aerie Pharmaceuticals Inc. He contributes to the strategic direction of the company by providing his expertise in the pharmaceutical field. As a director, he participates in board meetings and helps assess the company's performance and opportunities. Gerald D. Cagle is dedicated to Aerie Pharmaceuticals' mission and its sustainable growth.
